Steven Cohen’s Revolution Medicines RVMD Stock Holding History

Steven Cohen’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3M	Buy	+60,276	New	+$8.8M	0.01%	1206
2026 Q1	–	Sell	-446,616	Closed	-$45.1M	–	4400
2025 Q4	$35.6M	Buy	+446,616	New	+$29.3M	0.04%	571
2024 Q3	–	Sell	-227,922	Closed	-$8.85M	–	2295
2024 Q2	$8.85M	Buy	+227,922	New	+$8.52M	0.02%	656
2023 Q4	–	Sell	-270	Closed	-$7.47K	–	2726
2023 Q3	$7.47K	Buy	+270	New	+$8.01K	﹤0.01%	2343
2023 Q1	–	Sell	-383,339	Closed	-$9.13M	–	2508
2022 Q4	$9.13M	Buy	+383,339	New	+$8.15M	0.03%	581
2022 Q3	–	Sell	-27,667	Closed	-$539K	–	1690
2022 Q2	$539K	Sell	27,667 -364,431	-93%	-$7.09M	﹤0.01%	1169
2022 Q1	$10M	Buy	+392,098	New	+$8.53M	0.04%	513
2021 Q4	–	Sell	-55,000	Closed	-$1.51M	–	1269
2021 Q3	$1.51M	Sell	55,000 -137,600	-71%	-$4M	0.01%	813
2021 Q2	$6.11M	Buy	+192,600	New	+$6.72M	0.03%	570

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Steven Cohen's RVMD Position: Q2 2026 in Review

Steven Cohen opened a new position in Revolution Medicines (RVMD) in Q2 2026: 60,276 shares worth $11.3M. The stake represents 0.01% of the portfolio and ranks #1206 among its holdings. This is a return to the name: Steven Cohen previously reported a position in RVMD as recently as Q4 2025.

Steven Cohen first reported a position in RVMD in Q2 2021 and has held it in 9 quarters since. The position peaked at $35.6M in Q4 2025. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Steven Cohen held 60,276 shares of Revolution Medicines worth $11.3M as of Q2 2026.
Revolution Medicines was a new Steven Cohen position in Q2 2026.
Revolution Medicines made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1206 holding.
Steven Cohen first reported a position in Revolution Medicines in Q2 2021 and has held it in 9 quarters since.
Steven Cohen's Revolution Medicines position peaked at $35.6M in Q4 2025.
688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.